Recall Register

Xstrahl Limited: FDA recalls

Newest recall start date in this list: . X80 RADiant Photoelectric Therapy System

FDA enforcement events from 2021 to 2022; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Xstrahl Limited as the recalling firm in 3 events. The events have 3 product records. The recalls started from 2021 to 2022. All the events are device recalls. By FDA enforcement events, Xstrahl Limited is number 1,114 of 1,629 firms that have a page. Events that Xstrahl Limited started: none in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

3 events, newest first.

FDA enforcement events of Xstrahl Limited
InitiatedProduct (first record)TypeClassRecordsStatus
27 Apr 2022X80 RADiant Photoelectric Therapy SystemDeviceClass II1Ongoing
27 Aug 2021Treatment applicator for Gulmay Medical 150 or Xstrahl 150 superficial X-ray therapy systemDeviceClass II1Terminated
26 Apr 2021Concerto User Interface Software provided with the following systems: (1) Xstrahl 100 Electronic Brachytherapy - 100kV Superficial X-Ray Therapy System; (2) Xstrahl 150 Electronic Brachytherapy - 150kV Superficial X-Ray Therapy System; (3) Xstrahl 200 - 225kV Superficial / Orthovoltage X-Ray Therapy System; (4)…DeviceClass II1Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

Xstrahl Limited: events for each product type
TypeEvents
Device3
Xstrahl Limited: events in each class
ClassEvents
Class II3
Share of the events of the firm in Class I
0%
Share of all events on the register in Class I
18%
Events with the status Ongoing
1

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Xstrahl Limited, by the year that the recall started. The largest year is 2021, with 2 events.

Official channels

Cite this page

Recall Register. Xstrahl Limited: FDA recalls. https://recallregister.com/firm/xstrahl-limited/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
N/A

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Xstrahl Limited have?
Class II: 3 events. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of Xstrahl Limited?
FDA event 90231, which the firm started on 27 Apr 2022. The first product in the record is: X80 RADiant Photoelectric Therapy System
How many FDA recalls of Xstrahl Limited have the status Ongoing?
1 event has the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.